The Pharmacokinetics of P1101 + Ribavirin in Interferon Treatment-Naïve Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection
Clinical trial NCT04774107 · COMPLETED
Trial details
- NCT number
- NCT04774107
- Sponsor
- PharmaEssentia
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-26
- Primary completion
- 2022-07-18
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.